Phase 2 Start
JAZZ: Phase 2 Start: A Pilot Study, Open-Label Study of ONC201 for Refractory Meningioma
December 1, 2026 · onc201. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 1, 2026
- Company
- Jazz Pharmaceuticals plc (JAZZ)
- Drug
- onc201
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Start~month
Phase 2 Start: A Pilot Study, Open-Label Study of ONC201 for Refractory Meningioma
- Drug
- onc201
- Indication
- Meningioma; Refractory Meningioma; Relapsed Meningioma